Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.

Abstract

BACKGROUND Studies of Malawi's option B+ programme for HIV-positive pregnant and breastfeeding women have reported high loss to follow-up during pregnancy and at the start of antiretroviral therapy (ART), but few data exist about retention during breastfeeding and after weaning. We examined loss to follow-up and retention in care in patients in the option B… (More)
DOI: 10.1016/S2352-3018(16)00008-4

Topics

Cite this paper

@article{Haas2016RetentionIC, title={Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.}, author={Andreas D. Haas and Lyson Tenthani and Malango T. Msukwa and Kali Tal and Andreas Jahn and Oliver Jintha Gadabu and Adrian Spoerri and Frank Chimbwandira and Joep J.G. van Oosterhout and O Keiser}, journal={The lancet. HIV}, year={2016}, volume={3 4}, pages={e175-82} }